Search
About
Our Story
Leadership Team
Board of Directors
3D Technology Platform
3D Bioprinting
High Throughput 3D models
Disease Models: Technology Agnostic
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Investor Kit
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Search for:
News & Events
About
Our Story
Leadership Team
Board of Directors
3D Technology Platform
3D Bioprinting
High Throughput 3D models
Disease Models: Technology Agnostic
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Investor Kit
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Upcoming Events
There are no upcoming events at this time
Recent Press Releases
Mar 21, 2023
Organovo Announces FXR Program
Nov 15, 2022
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
Recent Media
May 6, 2019
Organovo: Bioprinting Could be the New Solution to Organ Transplantation
Oct 19, 2018
3D Method Uses Patients' Own Cells to Repair Tissue Damage
About
Our Story
Leadership Team
Board of Directors
3D Technology Platform
3D Bioprinting
High Throughput 3D models
Disease Models: Technology Agnostic
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Investor Kit
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact